masthead-news

News & Events

HTG EdgeSeq Technology Highlighted in Multiple Posters Presented by Pharma Partners at the 2020 American Association for Cancer Research Virtual Meeting

TUCSON, Ariz. , June 23, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced its HTG EdgeSeq technology was highlighted in multiple posters presented by global pharma company partners

Read More

Posted on:
 

HTG Introduces the HTG EdgeSeq Pan B-Cell Lymphoma Panel

Comprehensive Panel Designed to Provide Molecular Characterization of Aggressive Lymphomas TUCSON, Ariz. , June 18, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the pre-launch

Read More

Posted on:
 

HTG EdgeSeq Technology Highlighted in Several Posters at ASCO

Posters span each of HTG’s customer types, including Pharma, Academic and Transmed, and several geographies TUCSON, Ariz. , June 02, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced

Read More

Posted on:
 

HTG Molecular Diagnostics Reports First Quarter 2020 Results

Call scheduled for today, May 13, at 4:30pm ET TUCSON, Ariz. , May 13, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the first quarter ended March 31,

Read More

Posted on:
 

Page last updated September 03, 2020